Gamma Investing LLC Roivant Sciences Ltd. Transaction History
Gamma Investing LLC
- $1.99 Trillion
- Q4 2025
A detailed history of Gamma Investing LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Gamma Investing LLC holds 11,039 shares of ROIV stock, worth $223,981. This represents 0.01% of its overall portfolio holdings.
Number of Shares
11,039
Previous 9,302
18.67%
Holding current value
$223,981
Previous $141 Million
70.21%
% of portfolio
0.01%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding ROIV
# of Institutions
379Shares Held
443MCall Options Held
6.03MPut Options Held
2.52M-
Morgan Stanley New York, NY44.3MShares$899 Million0.04% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X040.3MShares$818 Million4.61% of portfolio
-
Vanguard Group Inc Valley Forge, PA38.8MShares$787 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$718 Million0.01% of portfolio
-
Qvt Financial LP New York, NY29.4MShares$596 Million36.4% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $14.3B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...